Will the 25th Amendment be used during Trump's Presidency?

**Stage 1 — Blind analysis (ignore market prices):**

- Context summary: The 25th Amendment can be triggered voluntarily (Section 3) if a President concedes inability, or involuntarily (Section 4) if the Vice President and a majority of the Cabinet declare incapacity and Congress either accepts or overrides that declaration. Historically Section 4 has never been used. There is currently no formal medical evidence or Cabinet/VP action indicating incapacity; public commentary has raised concerns about Trump's health but remains political opinion.

- Probability drivers (independent view): I separate the two main pathways and estimate their likelihoods over the remaining ~2.5 years of the term: - Section 3 (voluntary, temporary transfer): reasonably possible if the President undergoes surgery, a medical procedure, or temporarily concedes inability for treatment. For an 80-year-old President, the baseline chance of needing a short-duration incapacitating procedure over 2–3 years is non-negligible. I estimate roughly a 12% chance Section 3 gets used at least once (e.g., for planned surgery or clearly temporary impairment). - Section 4 (involuntary removal or declaration of incapacity): much harder politically. It requires the VP + majority of Cabinet to act against a sitting President and then sustain that assertion in Congress (or fail to, which returns power to the President). Given modern polarization, the high loyalty of Trump's Cabinet, and the enormous political cost, the chance is low. I estimate roughly a 6% chance of Section 4 being invoked over the term (this includes both successful and unsuccessful attempts to trigger the formal mechanism because an attempt is still a 'use' in some definitions; if you require a completed transfer, the number would be smaller).

- Combined independent probability: combining the above without double-counting (some scenarios overlap but are distinct pathways) leads me to an overall independent estimate around 18% that the 25th Amendment will be used at least once during the remainder of the presidency.

- Qualitative reasoning: The largest single contributor is routine medical unpredictability for an elderly person — sudden stroke, cardiac event, or surgery that requires anesthesia could prompt a Section 3 transfer or prompt the VP/Cabinet to act under Section 4 if the President is unreachable or clearly incapacitated. Political realities — Cabinet loyalty, GOP control of many institutions, the recent Supreme Court rulings strengthening executive authority, and the high congressional thresholds — substantially lower the chance of a politically motivated Section 4 removal. Public commentary and press speculation increase attention but do not materially increase the procedural likelihood unless it provokes actors with constitutional authority.

**Stage 2 — Market calibration (compare to current market price Yes=0.26):**

- Market snapshot: The market price implies a 26% chance of the 25th Amendment being used. That is meaningfully above my independent estimate of 18% (an 8-point gap).

- Why the market might be higher: - News and salience bias: High-profile commentary about age/health (and dramatic language in media) tends to inflate perceived risk among traders who react to headlines rather than detailed institutional barriers. - Tail-risk hedging and crowd psychology: Some traders may buy Yes as a hedge against an extreme-event scenario (sudden incapacitation) and are willing to pay a premium for asymmetric payoffs. - Liquidity and order flow: With significant volume (147k+ contracts), retail-driven flows and algorithmic strategies may push price above an analytically grounded level.

- Why the market might also be underpricing (less likely here): If new or secret medical information exists to which some informed traders have access, the market could be understating risk. I do not see evidence of that in the provided context.

- Conclusion on mispricing: The market at 26% appears slightly overpriced relative to a sober institutional/legal analysis. The gap is not huge — both figures place the event as unlikely but possible — but the market premium seems driven more by political salience and headline risk than by institutional feasibility. Traders sensitive to constitutional mechanics and political incentives would prefer a lower price around the mid-to-high teens.

- Practical implication: If one believes my independent 18% estimate, selling Yes exposure near 26% offers positive expected value; conversely, buying Yes only makes sense if you assign a materially higher probability (>=26%) because the market is already reflecting elevated headline-based risk.